Medication info
Travit Semi Sustained Release Tablet

Travit Semi Sustained Release Tablet

Prescription medicationTablet경구
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
(주)씨티씨바이오
Appearance
Pale yellow round sustained release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003336 · Approved 2020.05.08 · Insurance code 669502590

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
The initial dosage of 2 tablets is recommended, and thereafter, the dosing interval should be at least 12 hours, ensuring not to exceed 8 tablets in a day. Avoid prolonged use beyond necessity, and in cases requiring long-term use, regular monitoring should be conducted. Elderly patients should generally receive the standard adult dosage; however, those over 75 years old should be administered at least 12 hours apart.

Ingredients

Manufacturer
(주)씨티씨바이오

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

The initial dosage of 2 tablets is recommended, and thereafter, the dosing interval should be at least 12 hours, ensuring not to exceed 8 tablets in a day. Avoid prolonged use beyond necessity, and in cases requiring long-term use, regular monitoring should be conducted. Elderly patients should generally receive the standard adult dosage; however, those over 75 years old should be administered at least 12 hours apart.

Precautions

This medication may affect liver function, so individuals who consume alcohol in amounts exceeding certain limits daily must consult with a physician or pharmacist before taking it. If any rashes or allergic reactions occur while taking this medication, stop taking it immediately and consult with a healthcare professional. Due to the risk of seizures, caution should be exercised in patients with a history of seizures or those taking medications that may increase seizure risk. Patients with compromised respiratory function or severe acute bronchial asthma may experience significant respiratory depression from this medication, thus it should be administered under medical supervision. This medication can affect the central nervous system, leading to drowsiness or dizziness, so caution is needed when driving or operating machinery. Patients with impaired liver or kidney functions may require dose adjustments, and administration should be avoided in cases of severe impairment. Women who are pregnant or breastfeeding must consult a physician before taking this medication, and it is especially not recommended during breastfeeding. Abruptly stopping this medication may lead to withdrawal symptoms, hence the dosage should be gradually reduced as per a doctor's instructions. The risk of respiratory depression and severe side effects increases when this medication is taken with other central nervous system depressants or alcohol, so combination should be avoided or carefully monitored. In case of overdose, there is a risk of severe respiratory depression and liver damage, so the prescribed dosage should be strictly adhered to, and if an overdose is suspected, immediate medical attention should be sought.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pale skin, severe allergic reactions, high fever with severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, cough accompanied by fever and respiratory issues, yellowing of skin or eyes (jaundice), profound lethargy, liver abnormalities (jaundice), sudden and severe

Mild side effects

  • Weakness
  • fatigue
  • flushing
  • rigidity
  • fainting
  • withdrawal symptoms
  • hypertension
  • exacerbation of hypertension
  • hypotension
  • arrhythmia
Show 30 more
  • palpitations
  • tachycardia
  • dizziness
  • headache
  • tremors
  • ataxia
  • increased muscle tone
  • migraines
  • worsening migraines
  • involuntary muscle contractions
  • sensory abnormalities
  • confusion
  • dizziness
  • nausea
  • constipation
  • diarrhea
  • dyspepsia
  • flatulence
  • dry mouth
  • vomiting
  • dysphagia
  • blood in stool
  • tongue swelling
  • decreased appetite
  • anxiety
  • confusion
  • euphoria
  • insomnia
  • irritability
  • drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture ingress, at a room temperature between 1°C and 30°C. Storing it this way will help maintain the effectiveness of the medication and ensure its safe use.

Appearance and packaging

Appearance

Pale yellow round sustained release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.